{"id":5143,"date":"2023-09-10T18:30:39","date_gmt":"2023-09-10T18:30:39","guid":{"rendered":"https:\/\/csiag.eu\/?p=5143"},"modified":"2025-06-18T15:30:54","modified_gmt":"2025-06-18T15:30:54","slug":"izraksts-no-us-patenta-us11107588-b2","status":"publish","type":"post","link":"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/","title":{"rendered":"Izraksts - ASV patents US11,107,588 B2"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Satura r\u0101d\u012bt\u0101js<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Methoden_und_Systeme_zur_Priorisierung_von_Behandlungen_Impfungen_Tests_und_oder_Aktivitaten_unter_Wahrung_der_Privatsphare_des_Einzelnen\" >Metodes un sist\u0113mas \u0101rst\u0113\u0161anas, vakcin\u0101cijas, testu un\/vai darb\u012bbu priorit\u0101\u0161u noteik\u0161anai, vienlaikus iev\u0113rojot personas priv\u0101tumu.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#%E2%80%9ETatsachliche_Geolokalisierungsdaten_des_Einzelnen\" >\"Faktiskie \u0123eolokaliz\u0101cijas dati par indiv\u012bdu<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Historische_medizinische_Daten_des_Einzelnen\" >personas v\u0113sturiskie medic\u012bniskie dati<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Aktuelle_medizinische_Daten_des_Einzelnen\" >personas pa\u0161reiz\u0113jie medic\u012bniskie dati<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Informationen_von_Dritten_zum_Einzelnen\" >Tre\u0161o pu\u0161u inform\u0101cija par priv\u0101tperson\u0101m<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Spezielle_Pflicht-App\" >\u012apa\u0161a oblig\u0101t\u0101 lietotne<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Spezielle_freiwillige_App\" >\u012apa\u0161a br\u012bvpr\u0101t\u012bga lietotne<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Uberwachungsverhalten_des_Subjekts\" >Objekta nov\u0113ro\u0161anas uzved\u012bba<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Exemplarische_Bewertungsmethode\" >V\u0113rt\u0113\u0161anas metodes piem\u0113rs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Vom_Score_bis_zur_Behandlung\" >No rezult\u0101ta l\u012bdz \u0101rst\u0113\u0161anai<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Information_der_Offentlichkeit\" >Inform\u0101cija sabiedr\u012bbai<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/#Exemplarische_Simulationen\" >Paraugu simul\u0101cijas<\/a><\/li><\/ul><\/nav><\/div>\n<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Las\u012b\u0161anas laiks<\/span> <span class=\"rt-time\"> 8<\/span> <span class=\"rt-label rt-postfix\">protokols<\/span><\/span>\n<p class=\"wp-block-paragraph\">- <a href=\"https:\/\/patents.google.com\/?inventor=Gal+EHRLICH\" target=\"_blank\" rel=\"noopener\">Gal EHRLICH<\/a>, <a href=\"https:\/\/patents.google.com\/?inventor=Maier+Fenster\" target=\"_blank\" rel=\"noopener\">Maier logi<\/a> -<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Methoden_und_Systeme_zur_Priorisierung_von_Behandlungen_Impfungen_Tests_und_oder_Aktivitaten_unter_Wahrung_der_Privatsphare_des_Einzelnen\"><\/span><em>Metodes un sist\u0113mas \u0101rst\u0113\u0161anas, vakcin\u0101cijas, testu un\/vai darb\u012bbu priorit\u0101\u0161u noteik\u0161anai, vienlaikus iev\u0113rojot personas priv\u0101tumu.<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">T\u0101l\u0101k ir autom\u0101tiski tulkots izraksts no iepriek\u0161 min\u0113t\u0101 ASV patenta. <a href=\"https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/US-Patent.pdf\">US11,107,588 B2<\/a>kas pa\u0161laik cirkul\u0113 soci\u0101lajos medijos. Patents esot ietverts izgudrojums, kas tiek izmantots mobil\u0101 t\u0101lru\u0146a masta sazi\u0146ai ar cilv\u0113kiem, kuriem ir injic\u0113ts graphene (graphene oxide).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patents attiecas uz \u010detriem citiem patentu pieteikumiem, tostarp trim Izra\u0113l\u0101 (<a href=\"https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/Pat-285476.pdf\">277083<\/a>, 276665* un 276648*), k\u0101 ar\u012b AAE (Apvienotie Ar\u0101bu Emir\u0101ti) P6001304\/2020, kas, \u0161\u0137iet, nav pieejams internet\u0101.<br>* noraid\u012bts neatbild\u0113tas sarakstes d\u0113\u013c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patents, t\u0101pat k\u0101 Izra\u0113las patents, faktiski neapraksta nek\u0101du tehnolo\u0123iju, kas jebk\u0101d\u0101 veid\u0101 izmanto graf\u0113nu; termins \"graf\u0113na oks\u012bds\" nav min\u0113ts nevien\u0101 no patentiem!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tom\u0113r ASV patentu tom\u0113r ir v\u0113rts izlas\u012bt, jo tas pier\u0101da, ka tie, kas uzskata, ka \"... man nav ko sl\u0113pt...\", k\u013c\u016bd\u0101s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neatkar\u012bgi no t\u0101, vai runa ir par mobilajiem t\u0101lru\u0146iem, kred\u012btkart\u0113m vai tie\u0161saistes GPS kar\u0161u pakalpojumu izmanto\u0161anu, \u0161\u0101di dati atkl\u0101j daudz vair\u0101k, nek\u0101 \u0161\u0137iet no pirm\u0101 acu uzmetiena. Tie \u013cauj izveidot prec\u012bzus p\u0101rvieto\u0161an\u0101s un sastap\u0161an\u0101s profilus hronolo\u0123isk\u0101 sec\u012bb\u0101 un t\u0101d\u0113j\u0101di sniedz datus, kas \u013cauj veikt selekt\u012bvu uzraudz\u012bbu, no\u0161\u0137ir\u0161anu un pas\u0101kumus, kuri, l\u012bdz\u012bgi k\u0101 CN paz\u012bstam\u0101 soci\u0101lo kred\u012btu sist\u0113ma, \u013cauj ietekm\u0113t katra indiv\u012bda uzved\u012bbu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Izraksts (teksts kurs\u012bv\u0101):<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9ETatsachliche_Geolokalisierungsdaten_des_Einzelnen\"><\/span><em>\"Faktiskie \u0123eolokaliz\u0101cijas dati par indiv\u012bdu<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos tiek uzraudz\u012bti katra indiv\u012bda faktiskie izm\u0113r\u012btie \u0123eolok\u0101cijas dati, lai nov\u0113rt\u0113tu to potenci\u0101lu attiec\u012bb\u0101 uz citiem indiv\u012bdiem. Da\u017eos iemiesojumos indiv\u012bdi, kuri dienas laik\u0101 uzr\u0101da lielu kust\u012bbu teritorij\u0101s, kur atrodas citi indiv\u012bdi, sa\u0146em augstu nov\u0113rt\u0113jumu. Da\u017eos veidos katra indiv\u012bda faktiskos \u0123eolok\u0101cijas datus apvieno ar vienu vai vair\u0101kiem no \u0161iem elementiem:<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>1. elektronisk\u0101s ier\u012bces, piem\u0113ram, savu mobilo t\u0101lru\u0146u atra\u0161an\u0101s vietu, ko nodro\u0161ina GPS.<\/em><\/li>\n\n\n\n<li><em>2. sejas atpaz\u012b\u0161anas tehnolo\u0123ijas izmanto\u0161ana, pamatojoties uz vienu vai vair\u0101kiem no \u0161\u0101diem elementiem: a ) videonov\u0113ro\u0161anas dati, kas sa\u0146emti no pieejamiem avotiem, piem\u0113ram, ielu kamer\u0101m, bankom\u0101tiem, priv\u0101t\u0101m nov\u0113ro\u0161anas kamer\u0101m veikalos, \u0113k\u0101s un m\u0101j\u0101s u. c.; b ) soci\u0101lie mediji.<\/em><\/li>\n\n\n\n<li><em>3. digit\u0101l\u0101s darb\u012bbas, piem\u0113ram, kred\u012btkar\u0161u izmanto\u0161ana, IP adrese, ko izmanto, lietojot datoru vai elektronisko ier\u012bci, antenas, kas sa\u0146em datus t\u0101lru\u0146a zvana laik\u0101.<\/em><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u0113c izv\u0113les vai papildus \u0161\u0101dos faktiskajos \u0123eogr\u0101fisk\u0101s atra\u0161an\u0101s vietas datos izmanto faktisko personu kontakta identifik\u0101cijas datus vai to viet\u0101.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Historische_medizinische_Daten_des_Einzelnen\"><\/span><em>personas v\u0113sturiskie medic\u012bniskie dati<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos, lai noteiktu rezult\u0101tu, tiek izv\u0113rt\u0113ti katra indiv\u012bda v\u0113sturiskie medic\u012bniskie dati. Piem\u0113ram, k\u0101 min\u0113ts iepriek\u0161, personas ar hronisku klepu sa\u0146em augstu punktu skaitu, jo t\u0101m var b\u016bt liel\u0101ka iesp\u0113jam\u012bba p\u0101rnest infekcijas slim\u012bbu\/virusu\/patog\u0113nu. Da\u017eos gad\u012bjumos personas ar fona slim\u012bbu, kas palielina slim\u012bbas p\u0101rne\u0161anas iesp\u0113jam\u012bbu, sa\u0146em augstu punktu skaitu.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aktuelle_medizinische_Daten_des_Einzelnen\"><\/span><em>personas pa\u0161reiz\u0113jie medic\u012bniskie dati<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos iemiesojumos pand\u0113mijas laik\u0101 tiek uzraudz\u012bti visi jaunie medic\u012bniskie dati, kas attiecas uz katru indiv\u012bdu, lai noteiktu, vai jaunie dati nor\u0101da uz izmai\u0146\u0101m indiv\u012bda medic\u012bniskaj\u0101 st\u0101vokl\u012b attiec\u012bb\u0101 uz vi\u0146a potenci\u0101lu infic\u0113t citus. Ja indiv\u012bdam saska\u0146\u0101 ar iepriek\u0161 min\u0113to piem\u0113ru tiek diagnostic\u0113ts hronisks klepus, vi\u0146a r\u0101d\u012bt\u0101js palielin\u0101sies (piem\u0113ram, kopum\u0101 un\/vai vienam kontaktam).<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Informationen_von_Dritten_zum_Einzelnen\"><\/span><em>Tre\u0161o pu\u0161u inform\u0101cija par priv\u0101tperson\u0101m<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos tre\u0161o personu inform\u0101ciju izv\u0113rt\u0113 personas, kas inform\u0113 par citiem, lai noteiktu, vai inform\u0101cijai ir j\u0101ietekm\u0113 v\u0113rt\u0113jums. Piem\u0113ram, ja tre\u0161\u0101 persona inform\u0113, ka persona, kas uzr\u0101d\u012bjusi maz kust\u012bbu datu un sa\u0146\u0113musi zemu v\u0113rt\u0113jumu, paties\u012bb\u0101 veic daudz kust\u012bbu, p\u0113c inform\u0101cijas p\u0101rbaudes attiec\u012bgi main\u0101s v\u0113rt\u0113jums. Ir ar\u012b pret\u0113ji, piem\u0113ram, ja tre\u0161\u0101 persona inform\u0113, ka persona, kas uzr\u0101d\u012bjusi daudz kust\u012bbu datu un sa\u0146\u0113musi augstu punktu skaitu, paties\u012bb\u0101 uzturas m\u0101j\u0101s, p\u0113c tam, kad inform\u0101cija ir p\u0101rbaud\u012bta, attiec\u012bgi var main\u012bties ar\u012b punktu skaits.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Spezielle_Pflicht-App\"><\/span><em>\u012apa\u0161a oblig\u0101t\u0101 lietotne<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos gad\u012bjumos, \u0146emot v\u0113r\u0101 pand\u0113mijas izplat\u012bbu, vald\u012bba var likt iedz\u012bvot\u0101jiem savos viedt\u0101lru\u0146os (vai cit\u0101s viedier\u012bc\u0113s, piem\u0113ram, plan\u0161etdatoros, viedpulkste\u0146os, viedbrill\u0113s u. c.) instal\u0113t \u012bpa\u0161u lietotni, lai pal\u012bdz\u0113tu vald\u012bbai veikt vakcin\u0101cijas proced\u016bru lo\u0123istiku. Da\u017eos variantos vald\u012bba (vai cita strukt\u016bra) nodro\u0161ina iedz\u012bvot\u0101jiem \u0161\u0101das \u012bpa\u0161as viedier\u012bces. Da\u017eos iemiesojumos lietotne un\/vai viedier\u012bce ir konfigur\u0113ta t\u0101, lai visu laiku sniegtu inform\u0101ciju par lietot\u0101ja atra\u0161an\u0101s vietu, izmantojot Bluetooth, un lai (sazin\u0101tos, piem\u0113ram, ar) blakus eso\u0161aj\u0101m viedier\u012bc\u0113m, lai nov\u0113rt\u0113tu mijiedarb\u012bbu starp lietot\u0101jiem, piem\u0113ram, lietot\u0101ju tuvumu, lietot\u0101ju p\u0101rvieto\u0161anos utt.) Da\u017eos izgudrojuma variantos var izmantot eso\u0161o programmat\u016bru, piem\u0113ram, gan Android, gan uz Android balst\u012btiem mobilajiem t\u0101lru\u0146iem ir programmat\u016bra (piem\u0113ram, k\u0101 oper\u0113t\u0101jsist\u0113mas pakalpojums), kas var noteikt citu tuvumu, \u0161\u0101du programmat\u016bru var izmantot vai uzlabot, lai nodro\u0161in\u0101tu \u0161eit aprakst\u012bt\u0101s funkcijas.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos \u0161\u0101du lietotni var izmantot, lai sniegtu inform\u0101ciju par to, cik daudz unik\u0101lu cilv\u0113ku lietot\u0101js satiek. Piem\u0113ram, konkr\u0113ts lietot\u0101js var satikt daudzus cilv\u0113kus, bet tie vienm\u0113r ir vieni un tie pa\u0161i cilv\u0113ki. Savuk\u0101rt cits lietot\u0101js var satikt maz\u0101k cilv\u0113ku, bet katrs no tiem ir cits cilv\u0113ks. Da\u017eos veidos otrs lietot\u0101js var sa\u0146emt augst\u0101ku punktu skaitu, un t\u0101p\u0113c ar vi\u0146u var r\u012bkoties vispirms. Da\u017eos iemiesojumos \u0161\u0101du lietotni un\/vai viedier\u012bces izmanto ar\u012b vakcin\u0101cijas proced\u016bru gaitas un vakcin\u0101cijas proced\u016bras efektivit\u0101tes nov\u0113rt\u0113\u0161anai. Da\u017eos iemiesojumos no katra lietot\u0101ja sa\u0146emtie individu\u0101lie dati tiek savienoti ar inform\u0101ciju par vi\u0146a vesel\u012bbas st\u0101vokli (slims, vakcin\u0113ts, izvese\u013cojies u. c.), lai turpm\u0101k nov\u0113rt\u0113tu vakcin\u0101cijas proced\u016bru progresu un vakcin\u0101cijas proced\u016bras efektivit\u0101ti. P\u0113c izv\u0113les, ja lietot\u0101ja satiktie indiv\u012bdi ir vakcin\u0113ti vai cit\u0101di klasific\u0113ti k\u0101 im\u016bni, \u0161ie kontakti var netikt ieskait\u012bti un\/vai tiem var pie\u0161\u0137irt zem\u0101ku svaru.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos gad\u012bjumos lietotni izmanto ar\u012b, lai nos\u016bt\u012btu lietot\u0101jiem personaliz\u0113tu sazi\u0146u, piem\u0113ram, lai vi\u0146i var\u0113tu vakcin\u0113ties. Da\u017eos iemiesojumos, \u0146emot v\u0113r\u0101 no lietotnes sa\u0146emto inform\u0101ciju, tiek veiktas noteiktas darb\u012bbas, piem\u0113ram, nos\u016bt\u012bta sazi\u0146a lietot\u0101jam, lai palielin\u0101tu vi\u0146a inform\u0113t\u012bbu par uzved\u012bbas noteikumiem pand\u0113mijas laik\u0101 ierasties un vakcin\u0113ties, lai izvair\u012btos no noteikt\u0101m viet\u0101m, kur past\u0101v augsts infic\u0113\u0161an\u0101s risks.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Spezielle_freiwillige_App\"><\/span><em>\u012apa\u0161a br\u012bvpr\u0101t\u012bga lietotne<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos, \u0146emot v\u0113r\u0101 pand\u0113miju, iedz\u012bvot\u0101ji tiek mudin\u0101ti instal\u0113t \u012bpa\u0161u lietotni, kur\u0101 tie, kas instal\u0113 lietotni, tiek apbalvoti. Da\u017eos veidos atl\u012bdz\u012bba ir priorit\u0101ra.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Uberwachungsverhalten_des_Subjekts\"><\/span><em>Objekta nov\u0113ro\u0161anas uzved\u012bba<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos subjekta uzved\u012bba tiek uzraudz\u012bta saist\u012bb\u0101 ar subjekta veiktaj\u0101m dro\u0161\u012bbas funkcij\u0101m, piem\u0113ram, maskas lieto\u0161anu (piem\u0113ram, analiz\u0113jot att\u0113lus, kas uz\u0146emti mobil\u0101 t\u0101lru\u0146a zvana vai cita mobil\u0101 t\u0101lru\u0146a ekr\u0101na laik\u0101), roku mazg\u0101\u0161anu (piem\u0113ram, analiz\u0113jot \u016bdens ska\u0146as vai kust\u012bbas, izmantojot viedpulksteni), soci\u0101lo distanc\u0113\u0161anos (piem\u0113ram, pamatojoties uz Bluetooth jaudas l\u012bmeni un\/vai NFC noteik\u0161anu), p\u0101rsl\u0113g\u0161anos starp vair\u0101k\u0101m atra\u0161an\u0101s viet\u0101m utt. Da\u017eos variantos tos uzrauga, izmantojot t\u0101s pa\u0161as ier\u012bces\/metodes, kas min\u0113tas iepriek\u0161.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Exemplarische_Bewertungsmethode\"><\/span><em>V\u0113rt\u0113\u0161anas metodes piem\u0113rs<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos katrs indiv\u012bds popul\u0101cij\u0101 ( piem\u0113ram, vair\u0101k nek\u0101 100, 1000, 10000 un\/vai 100000 indiv\u012bdu) sa\u0146em v\u0113rt\u0113jumu, kas nosaka katra indiv\u012bda potenci\u0101lo p\u0101rm\u0113r\u012bgas izkliedes pak\u0101pi. Da\u017eos iemiesojumos punktus nosaka k\u0101 kontaktu skaitu ( sk. \u0161eit ), un uzskait\u012bto kontaktu skaits ir no aptuveni 10 l\u012bdz aptuveni 100, p\u0113c izv\u0113les no aptuveni 100 l\u012bdz aptuveni 1000, p\u0113c izv\u0113les no aptuveni 1000 l\u012bdz aptuveni 10000, piem\u0113ram, 100, 400, 1000, 2000, 10000 vai vid\u0113ji lieli vai liel\u0101ki skait\u013ci. Da\u017eos variantos liela v\u0113rt\u012bba nosaka lielu potenci\u0101lu p\u0101rm\u0113r\u012bgai dispersijai, savuk\u0101rt maza v\u0113rt\u012bba nosaka mazu potenci\u0101lu p\u0101rm\u0113r\u012bgai dispersijai. Lai atvieglotu izgudrojuma skaidrojumus, tiek izmantota v\u0113rt\u0113\u0161anas skala no 0 l\u012bdz 100. Ir saprotams, ka var izmantot ar\u012b citas skalas, piem\u0113ram, siltuma kartes v\u0113rt\u0113jumu, decim\u0101lda\u013cu skalas u. c., kas visas ir iek\u013cautas izgudrojuma darb\u012bbas jom\u0101. Da\u017eos izgudrojuma variantos v\u0113rt\u0113jums ir atv\u0113rts. Piem\u0113ram, da\u017eos izgudrojuma variantos v\u0113rt\u0113jums ir normaliz\u0113ts attiec\u012bb\u0101 pret cit\u0101m v\u0113rt\u012bb\u0101m. Normaliz\u0101cijai nav j\u0101b\u016bt line\u0101rai. Da\u017eos izgudrojuma variantos rezult\u0101ts ir skal\u0101rs. Piem\u0113ram, da\u017eos izgudrojuma variantos v\u0113rt\u0113jums ir daudzdimensiju r\u0101d\u012bt\u0101js, tostarp p\u0101rsp\u012bl\u0113t\u0101 potenci\u0101la dimensija un uzved\u012bbas main\u012bguma dimensija). Piem\u0113ram, v\u0113rt\u0113jums ir daudzdimensiju, ieskaitot p\u0101rsp\u012bl\u0113\u0161anas potenci\u0101la dimensiju un uzved\u012bbas main\u012bguma dimensiju). v\u0113rt\u0113jums ir daudzdimensiju, ieskaitot p\u0101rsp\u012bl\u0113\u0161anas potenci\u0101la dimensiju un uzved\u012bbas main\u012bguma dimensiju).<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos rezult\u0101tu apr\u0113\u0137ina, izmantojot sv\u0113rt\u0101s v\u0113rt\u0113\u0161anas mode\u013cus, kuros viens vai vair\u0101ki faktori un\/vai komponenti tiek v\u0113rt\u0113ti saska\u0146\u0101 ar sa\u0146emtajiem inform\u0101cijas datiem. T\u0101l\u0101k 3. att\u0113l\u0101 par\u0101d\u012bta shematiska pl\u016bsmas sh\u0113ma, kur\u0101 att\u0113lota sv\u0113rt\u0101 v\u0113rt\u0113juma apr\u0113\u0137in\u0101\u0161anas metode saska\u0146\u0101 ar da\u017eiem izgudrojuma variantiem.<\/em><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" width=\"558\" height=\"1024\" src=\"https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/image-558x1024.png\" alt=\"\" class=\"wp-image-5146\" style=\"width:281px;height:515px\" srcset=\"https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/image-558x1024.png 558w, https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/image-163x300.png 163w, https:\/\/csiag.eu\/wp-content\/uploads\/2023\/09\/image.png 596w\" sizes=\"(max-width: 558px) 100vw, 558px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos sist\u0113ma sa\u0146em inform\u0101cijas datus par subjektu. <strong>302<\/strong>Da\u017eos veidos inform\u0101cijas dati ir sak\u0101rtoti atbilsto\u0161i inform\u0101cijas datu avotam. <strong>304<\/strong>. piem\u0113ram, elektronisk\u0101 inform\u0101cija <strong>306<\/strong>. viedt\u0101lru\u0146i, fotoapar\u0101ti, kred\u012btkar\u0161u inform\u0101cija u. c. <strong>308<\/strong>. \u0123eogr\u0101fisk\u0101 inform\u0101cija, piem\u0113ram, no GPS vai mobilo sakaru tor\u0146iem.<strong> 310<\/strong>. vald\u012bbas inform\u0101cija, piem\u0113ram, no tautas skait\u012b\u0161anas biroja vai EMR (elektronisk\u0101s medic\u012bnisk\u0101s kartes). <strong>312<\/strong>cilv\u0113ku inform\u0101ciju, piem\u0113ram, no cit\u0101m person\u0101m, kas aicina sniegt inform\u0101ciju par cit\u0101m person\u0101m un vienu vai vair\u0101kiem iepriek\u0161 min\u0113tajiem faktoriem un\/vai komponentiem. Da\u017eos variantos sist\u0113ma p\u0113c tam apr\u0113\u0137ina katras inform\u0101cijas da\u013cas sv\u0113rto punktu skaitu, p\u0113c izv\u0113les saska\u0146\u0101 ar iepriek\u0161 noteiktu krit\u0113riju. <strong>314<\/strong>. da\u017eos variantos sist\u0113ma p\u0113c tam no da\u017e\u0101diem sv\u0113rtajiem v\u0113rt\u0113jumiem izveido kopv\u0113rt\u0113jumu, p\u0113c izv\u0113les saska\u0146\u0101 ar iepriek\u0161 noteiktu krit\u0113riju. <strong>316<\/strong>Da\u017eos veidos sist\u0113ma nodro\u0161ina \u0101rst\u0113\u0161anas sec\u012bbas sarakstu, ko p\u0113c tam izmanto, lai faktiski \u0101rst\u0113tu popul\u0101ciju. <strong>318<\/strong>.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos v\u0113rt\u0113jums sast\u0101v no vair\u0101kiem komponentiem, piem\u0113ram, paredzam\u0101 varb\u016bt\u012bba, ka subjekts p\u0101rn\u0113s\u0101s infekcijas slim\u012bbu\/v\u012brusu\/patog\u0113nu, paredzam\u0101 varb\u016bt\u012bba, ka subjekts saslims ar infekcijas slim\u012bbu\/v\u012brusu\/patog\u0113nu, relat\u012bvais vesel\u012bbas risks subjektam, ja subjektam ir infekcijas slim\u012bba\/v\u012bruss\/patog\u0113ns, kait\u0113jums sabiedr\u012bbai, ja subjekts saslims ar infekcijas slim\u012bbu\/v\u012brusu\/patog\u0113nu; viens vai vair\u0101ki no iepriek\u0161 min\u0113tajiem fakultat\u012bvajiem datiem attiec\u012bb\u0101 uz datiem par fizisko tuvumu cit\u0101m person\u0101m.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos subjekta fizisk\u0101s aproksim\u0101cijas dati tiek apr\u0113\u0137in\u0101ti kop\u0101 ar citiem subjektiem, izmantojot vienu vai vair\u0101kus no \u0161iem veidiem:<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>1. to subjektu skaits, ar kuriem subjekts var kontakt\u0113ties;<\/em><\/li>\n\n\n\n<li><em>2. potenci\u0101lo un\/vai faktisko att\u0101lumu, k\u0101d\u0101 atrodas objekts l\u012bdz citiem objektiem;<\/em><\/li>\n\n\n\n<li><em>3. iesp\u0113jam\u0101s un\/vai faktisk\u0101s saskarsmes ar citiem subjektiem ilgums.<\/em><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos izgudrojuma veidos v\u0113rt\u0113jums tiek atjaunin\u0101ts un\/vai p\u0113c katra kontakta notikuma. Da\u017eos izgudrojuma variantos atjaunin\u0101\u0161ana notiek dienas beig\u0101s, potenci\u0101li apkopojot vair\u0101kas tik\u0161an\u0101s ar vienu un to pa\u0161u personu. P\u0113c izv\u0113les vai papildus punktu skaits tiek atjaunin\u0101ts par katru kontaktu notikumu s\u0113riju. Da\u017eos izgudrojuma variantos rezult\u0101tu apr\u0113\u0137ina p\u0113c tam, kad ir apkopoti visi kontakta notikumi, piem\u0113ram, pamatojoties uz kontaktu t\u012bkla anal\u012bzi, lai identific\u0113tu personas, kuras vakcin\u0101cijas gad\u012bjum\u0101 vislab\u0101k aptur\u0113tu infekciju. \u0160\u0101du anal\u012bzi var veikt, simul\u0113jot kontaktu t\u012bklu un izm\u0113\u0123inot da\u017e\u0101das vakcin\u0101cijas sh\u0113mas un\/vai izsl\u0113dzot da\u017e\u0101das personas un\/vai personu grupas.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Vom_Score_bis_zur_Behandlung\"><\/span><em>No rezult\u0101ta l\u012bdz \u0101rst\u0113\u0161anai<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos, tikl\u012bdz ir sasniegts katra indiv\u012bda rezult\u0101ts vai p\u0113c izv\u0113les liela skaita popul\u0101cijas indiv\u012bdu rezult\u0101ts, tiek izveidots saraksts ar sec\u012bbu, k\u0101d\u0101 katrs indiv\u012bds sa\u0146em \u0101rst\u0113\u0161anu. Da\u017eos variantos saraksts p\u0113c izv\u0113les tiek sadal\u012bts pa grup\u0101m, piem\u0113ram, visi indiv\u012bdi, kas ieguvu\u0161i no 100 l\u012bdz 90 punktiem, tiek sagrup\u0113ti A grup\u0101, kas sa\u0146em \u0101rst\u0113\u0161anu pirm\u0101. P\u0113c tam visi indiv\u012bdi, kas ieguvu\u0161i no 90 l\u012bdz 80 punktiem, tiek sagrup\u0113ti B grup\u0101, kas sa\u0146em \u0101rst\u0113\u0161anu k\u0101 otr\u0101, un t\u0101 t\u0101l\u0101k.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Information_der_Offentlichkeit\"><\/span><em>Inform\u0101cija sabiedr\u012bbai<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos veidos p\u0113c saraksta izveides personas tiek inform\u0113tas par to, kad un kur doties un sa\u0146emt \u0101rst\u0113\u0161anu, piem\u0113ram, izmantojot e-pastu, \u012bpa\u0161as lietotnes mobilajos t\u0101lru\u0146os, pla\u0161sazi\u0146as l\u012bdzek\u013cus u. c.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Exemplarische_Simulationen\"><\/span><em>Paraugu simul\u0101cijas<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos model\u0113\u0161anu un simul\u0101cijas veic specializ\u0113tos datoros, lai, piem\u0113ram, nov\u0113rt\u0113tu iesp\u0113jamo \u0101rst\u0113\u0161anas progresu un iesp\u0113jamo laiku, kad tiks sasniegta gan\u0101mpulka imunit\u0101te, un\/vai izv\u0113l\u0113tos da\u017e\u0101du parametru v\u0113rt\u012bbas. Da\u017eos variantos simul\u0101cijas ietver viena vai vair\u0101ku faktisko datu, kas sa\u0146emti no indiv\u012bdiem, ievieto\u0161anu, lai palaistu simul\u0113tus datus no indiv\u012bdiem (ja nepiecie\u0161ams, lai palaistu iesp\u0113jamos scen\u0101rijus). Da\u017eos iemiesojumos nov\u0113rt\u0113jumos un mode\u013cos izmanto vienu vai vair\u0101kus neironu t\u012bklus, ma\u0161\u012bnm\u0101c\u012b\u0161anos un specializ\u0113tas simul\u0101cijas.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos simul\u0101cij\u0101s tiek \u0146emta v\u0113r\u0101 un model\u0113ta varb\u016bt\u012bba, ka \u0101rst\u0113\u0161ana ( iedarbojas vai ) neiedarbojas uz indiv\u012bdu.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos simul\u0101cij\u0101s tiek \u0146emts v\u0113r\u0101 un model\u0113ts popul\u0101cijas veids, ar kuru konkr\u0113tais subjekts var saskarties, un potenci\u0101l\u0101 popul\u0101cija, ar kuru \u0161ie indiv\u012bdi var saskarties v\u0113l\u0101k. Piem\u0113ram, skolot\u0101ji, kuri sastopas ar daudziem b\u0113rniem, sa\u0146em augst\u0101ku simul\u0101cijas rezult\u0101tu, jo, ja un kad skolot\u0101js infic\u0113s b\u0113rnus, b\u0113rni atgriez\u012bsies m\u0101j\u0101s un potenci\u0101li infic\u0113s savas \u0123imenes. Savuk\u0101rt, piem\u0113ram, \u0101rsts, kas str\u0101d\u0101 cietum\u0101, iesp\u0113jams, sa\u0146ems zem\u0101ku simul\u0113to rezult\u0101tu, jo ieslodz\u012btie cilv\u0113ki no cietuma neaiziet un, visticam\u0101k, nevienu neinfic\u0113s. (Infekcija cietum\u0101 tiek tur\u0113ta vienatn\u0113).<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Da\u017eos variantos simul\u0101cijas tiek veiktas, lai nov\u0113rt\u0113tu parametru v\u0113rt\u012bbas, ko izmanto, lai identific\u0113tu supersp\u012bl\u0113t\u0101ju un, iesp\u0113jams, k\u0101 to at\u0161\u0137irt no parastiem indiv\u012bdiem.<\/em>\u201e<\/p>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Las\u012b\u0161anas laiks<\/span> <span class=\"rt-time\"> 8<\/span> <span class=\"rt-label rt-postfix\">protokols<\/span><\/span>- Gal EHRLICH, Maier Fenster - Metodes un sist\u0113mas \u0101rst\u0113\u0161anas, vakcin\u0101cijas, testu un\/vai darb\u012bbu priorit\u0101\u0161u noteik\u0161anai, vienlaikus saglab\u0101jot personas priv\u0101tumu T\u0101l\u0101k ir autom\u0101tiski tulkots izvilkums no iepriek\u0161 min\u0113t\u0101 ASV patenta US11,107,588 B2, kas pa\u0161laik cirkul\u0113 soci\u0101lajos medijos. Patents esot ietverts izgudrojums, kas ir...&nbsp;<a href=\"https:\/\/csiag.eu\/lv\/blog\/2023\/09\/10\/auszug-us-patent-us11107588-b2\/\" rel=\"bookmark\">Las\u012bt vair\u0101k \"<span class=\"screen-reader-text\">Izraksts - ASV patents US11,107,588 B2<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[628,2273,356,2274],"tags":[2283,2282,2281,2335,2331,567,2325,2315,2354,2360,2332,2323,2318,2314,2341,2346,2344,2336,524,551,1486,2294,2278,2313,2339,2312,2353,2317,2366,2365,2328,2290,2277,2337,2289,2326,2351,1118,2279,2358,2275,2361,2301,2295,2272,2324,2342,2299,2311,2302,1116,2296,2343,2355,2356,2327,2288,2300,2350,2276,2363,2338,2349,2320,2287,2308,2347,2362,2316,2352,2334,2348,2340,2284,238,1522,2306,2298,2357,2310,2359,2303,2319,2304,2286,2322,2293,2285,2309,2291,2297,2321,2307,2086,1028,2292,2333,2280,2345,2330,31,862,2305,2329],"class_list":["post-5143","post","type-post","status-publish","format-standard","hentry","category-corona","category-impfung","category-kommunikation","category-ueberwachung","tag-2283","tag-2282","tag-2281","tag-analyse","tag-ansteckungsrisiko","tag-antennen","tag-anwendung","tag-app","tag-begegnung","tag-behandlung","tag-belohnung","tag-benachbart","tag-benutzer","tag-bewegung","tag-bewertungsmethode","tag-bewertungsmodell","tag-bewertungsskala","tag-bildanalyse","tag-bluetooth","tag-bt","tag-chronisch","tag-computer","tag-daten","tag-dirtter","tag-distanzierung","tag-dritte","tag-entfernung","tag-funktionen","tag-gal-ehrlich","tag-gefaengnis","tag-geimpft","tag-geldautomat","tag-geolokalisierung","tag-geraeuschanalyse","tag-gesichtserkennung","tag-gesundheitsinformation","tag-gesundheitsrisiko","tag-gps","tag-graphene-oxide","tag-gruppe","tag-hany","tag-herdenimmunitaet","tag-hintergrunderkrankung","tag-identifizierung","tag-impfung","tag-impfverfahren","tag-individuen","tag-infekt","tag-infektion","tag-infektionserkrankung","tag-ip-adresse","tag-kontakt","tag-kontakte","tag-kontaktereignis","tag-kontaktnetz","tag-krank","tag-krankenakte","tag-krankheit","tag-krankheitserreger","tag-kreditkarte","tag-lehrer","tag-leistungspegel","tag-linear","tag-logistik","tag-massnahmen","tag-medizinische-daten","tag-mehrdimensional","tag-modell","tag-naehe","tag-naeherungsdaten","tag-nfc","tag-normalisierung","tag-ortswechsel","tag-p6001304-2020","tag-pandemie","tag-patent","tag-pathogen","tag-person","tag-personengruppe","tag-potenzial","tag-priorisierung","tag-punktzahl","tag-regierung","tag-score","tag-separation","tag-smartwatch","tag-soziale-medien","tag-sozialkredit-system","tag-status","tag-strassenkamera","tag-superspreader","tag-tablet-2","tag-uebertragen","tag-uebertragung","tag-ueberwachung","tag-ueberwachungskamera","tag-ueberwachungsverhalten","tag-us11107588-b2","tag-variabilitaet","tag-verhaltensregeln","tag-virus","tag-vorhersage","tag-wahrscheinlichkeit","tag-wiederhergestellt"],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts\/5143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/comments?post=5143"}],"version-history":[{"count":0,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts\/5143\/revisions"}],"wp:attachment":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/media?parent=5143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/categories?post=5143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/tags?post=5143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}